Disc Medicine paid its 5 named executives $25.3M in total in FY2025 (Dec). CEO John Quisel, J.D., Ph.D. was paid $10.0M of that.
Pay$100 in the stock at the end of FY21 → $273
Pay of each named executive
John Quisel, J.D., Ph.D.President and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Jean FranchiChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) |
2 years
Pamela Stephenson, M.P.H.Chief Commercial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) |
2 years
William Savage, M.D., Ph.D.Chief Medical Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Jonathan Yu, M.B.A.Chief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 5 peers with pay on file was $12.9M. The CEO of Disc Medicine was paid $10.0M, 22% below the median.
- 1Scholar Rock Holding
- 2Cogent Biosciences
- 3Protagonist Therapeutics
- 4Disc MedicineThis company
- 5IDEAYA Biosciences
- 6Kymera Therapeutics
- 789Bio, Inc.Not disclosed
- 8Akero Therapeutics, Inc.Not disclosed
- 9Centessa Pharmaceuticals plcNot disclosed
- 10Cullinan Therapeutics, Inc.Not disclosed
- 11Dyne TherapeuticsNot disclosed
- 12Edgewise TherapeuticsNot disclosed
- 13Fulcrum Therapeutics, Inc.Not disclosed
- 14Keros Therapeutics, Inc.Not disclosed
- 15Stoke Therapeutics, Inc.Not disclosed
- 16Syndax PharmaceuticalsNot disclosed
- 17Terns Pharmaceuticals, Inc.Not disclosed
- 18Viridian Therapeutics, Inc.Not disclosed
- 19iTeos Therapeutics, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.